Safety and Efficacy of Oxaliplatin and Fluoropyrimidine Regimens With or Without Bevacizumab As First-Line Treatment of Metastatic Colorectal Cancer: Results of the TREE Study

S. Hochster, Howard; L. Hart, Lowell; K. Ramanathan, Ramesh; H. Childs, Barrett; D. Hainsworth, John; L. Cohn, Allen; Wong, Lucas; Fehrenbacher, Louis; Abubakr, Yousif; Wasif Saif, M.; Schwartzberg, Lee; Hedrick, Eric

doi:10.1200/jco.2007.15.4138

Public

Safety and Efficacy of Oxaliplatin and Fluoropyrimidine Regimens With or Without Bevacizumab As First-Line Treatment of Metastatic Colorectal Cancer: Results of the TREE Study

Shared by NobleBlocks on Jul 20, 2008 • 12:00 AM UTC

Authors:

Howard S. Hochster

Lowell L. Hart

Ramesh K. Ramanathan

Abstract

Purpose To evaluate the safety and efficacy of three oxaliplatin and fluoropyrimidine regimens, with or without bevacizumab, as first-line treatment for metastatic colorectal cancer (CRC). Patients and Methods Patients with histologically documented metastatic or recurrent CRC and no prior treatment...

Discussions